Rheumatoid Arthritis Drugs Market to Reach USD 62,935 Mn By 2027 | Present Scenario on Growth Analysis & Key Players
September 23, 2022
Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 3.2% during the forecast period.
PORTLAND, OREGON, US, September 22, 2022 /EINPresswire.com/ -- Major factors driving the growth of the global Rheumatoid arthritis drug market include increasing prevalence of rheumatoid arthritis, increase in demand for rheumatoid arthritis drug therapy, increase in potential clinical pipeline candidates, increasing availability and awareness of safe drugs, increase in approvals. of biosimilar medicines, and the growth of an aging population worldwide.
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭@ https://www.alliedmarketresearch.com/request-sample/3753
The global arthritis drugs market is studied based on drug class, route of administration, sales channel, and region. By drug class, the market is segmented into disease-modifying anti-rheumatic drugs (DMARDs), nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, uric acid drugs, and others.
The DMARDs segment dominated the global market in 2019 and is expected to continue this trend during the forecast period. This is mainly due to the increased awareness associated with the use of DMARDs for the treatment of rheumatoid arthritis, the prevalence of rheumatoid arthritis, and the increase in obesity and overweight populations worldwide.
𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲@ https://www.alliedmarketresearch.com/purchase-enquiry/3753
Asia-Pacific is expected to experience the highest growth rate during the forecast period, mainly due to increasing prevalence of rheumatoid arthritis and increasing awareness among patients about the use of anti-rheumatic drugs. North America accounted for the largest share of the global arthritis drugs market in 2019 and is expected to remain dominant during the forecast period. This is an increase in research and development activities to develop new drugs and easy availability of arthritis drugs in the region.
𝐋𝐞𝐚𝐝𝐢𝐧𝐠 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:
• Abbvie Inc.
• Amgen Inc.
• Bristol-Myers Squibb Company
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd.
• Johnson & Johnson
• Merck & Co., Inc.
• Novartis Ag (Sandoz)
• Pfizer Inc.
• Ucb S.A.
• Deep Brain Stimulation Equipment Market Grows With Rising Neurological Disorders In South Korea: https://southkoreahealthcarepress.blogspot.com/2022/05/deep-brain-stimulation-equipment-market.html
• Demand for Plasma Fractionation Has Highly Increased across Vietnam: https://southkoreahealthcarepress.blogspot.com/2022/03/demand-for-plasma-fractionation-has.html
• Heparin Market Analysis in South Korea Region: Role of Heparin Drugs in Medicine: https://southkoreahealthcarepress.blogspot.com/2022/04/heparin-market-analysis-in-south-korea.html
• COVID-19 Impact on Workplace Wellness Market In South Korea Region: https://southkoreahealthcarepress.blogspot.com/2022/05/covid-19-impact-on-workplace-wellness.html
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP, based in Portland, Oregon. AMR provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.